Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangya Tongluo Formula is a Traditional Chinese Medicine (TCM) herbal prescription developed by the Oriental Hospital of Beijing University of Chinese Medicine. It is primarily investigated for its renal protective effects in patients with early to mid-stage hypertensive nephrosclerosis. The formula is designed to lower blood pressure and 'dredge collaterals' (improve microcirculation and reduce fibrosis) to mitigate hypertensive renal damage. Clinical research, including studies supported by the Capital Health Development and Scientific Research Projects, has focused on its ability to slow the progression of kidney damage in patients with hypertension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiangya tongluo formula.